• STA Pharmaceutical signs deal with Tesaro for zejula pharmaceutical-technology
    July 27, 2017
    STA Pharmaceutical, a US subsidiary of China-based company WuXi AppTec, has signed a new supply agreement with oncology-focused biopharmaceutical company Tesaro for certain starting and intermediate materials for zejula (niraparib).
PharmaSources Customer Service